Fei Chen

7.3k total citations · 3 hit papers
93 papers, 4.9k citations indexed

About

Fei Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fei Chen has authored 93 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 50 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Fei Chen's work include Cancer Cells and Metastasis (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and RNA modifications and cancer (10 papers). Fei Chen is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and RNA modifications and cancer (10 papers). Fei Chen collaborates with scholars based in China, United States and Saudi Arabia. Fei Chen's co-authors include Zhen Dong, Hongjuan Cui, Jiayi Zhang, Pengfei Shi, Guanghui Zhang, Gaichao Zhao, Wen Peng, Jie Xu, Xiaowen Wang and Liqun Yang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Fei Chen

88 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting cancer stem cell pathways for cancer therapy

2020 1.3k citations Liqun Yang, Pengfei Shi et al. Signal Transduction and Targeted Therapy profile →
CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness

2018 921 citations Fei Chen et al. profile →
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis

2014 609 citations Fei Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fei Chen China	27	2.7k	2.1k	1.4k	1.0k	519	93	4.9k
Shi‐Cang Yu China	34	2.6k 1.0×	2.1k 1.0×	1.6k 1.2×	1.1k 1.0×	540 1.0×	77	5.4k
Dingcheng Gao United States	26	2.8k 1.1×	2.5k 1.2×	1.8k 1.3×	936 0.9×	853 1.6×	36	5.1k
Anna Dubrovska Germany	37	2.8k 1.0×	2.4k 1.1×	1.4k 1.1×	568 0.6×	839 1.6×	94	5.0k
Moorthy P. Ponnusamy United States	43	3.4k 1.3×	2.3k 1.1×	1.0k 0.7×	998 1.0×	632 1.2×	113	5.4k
Wei‐Zhong Wu China	41	3.5k 1.3×	2.1k 1.0×	1.9k 1.4×	1.0k 1.0×	470 0.9×	107	5.7k
Aarthi Gopinathan United Kingdom	13	2.5k 0.9×	2.5k 1.2×	1.2k 0.9×	845 0.8×	390 0.8×	20	4.7k
Ivano Amelio Italy	33	2.9k 1.1×	1.4k 0.7×	1.8k 1.3×	505 0.5×	437 0.8×	84	4.7k
Lido Calorini Italy	37	2.1k 0.8×	1.3k 0.6×	1.2k 0.9×	656 0.6×	316 0.6×	106	3.9k
Xiaoxiang Guan China	38	2.5k 0.9×	2.0k 0.9×	1.6k 1.2×	508 0.5×	910 1.8×	173	4.7k
Roger R. Gomis Spain	30	3.4k 1.3×	2.5k 1.2×	1.6k 1.2×	544 0.5×	889 1.7×	67	6.0k

Countries citing papers authored by Fei Chen

Since Specialization

Citations

This map shows the geographic impact of Fei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Chen more than expected).

Fields of papers citing papers by Fei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Chen. The network helps show where Fei Chen may publish in the future.

Co-authorship network of co-authors of Fei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Chen. A scholar is included among the top collaborators of Fei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Chen. Fei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zhenyu, Yuan Shen, Xianxian Zhang, et al.. (2025). Prognostic value of multi-PLD ASL radiomics in acute ischemic stroke. Frontiers in Neurology. 15. 1544578–1544578. 2 indexed citations

Wang, Zhenyu, Xianxian Zhang, Qingqing Li, et al.. (2025). Machine learning-based prognostic prediction for acute ischemic stroke using whole-brain and infarct multi-PLD ASL radiomics. BMC Medical Imaging. 25(1). 267–267.

Chen, Fei, Jianyi Li, Xiaofan Du, et al.. (2025). Targeting Irgm1 to combat osteoporosis: suppressing ROS and restoring bone remodeling. Cell Death and Disease. 16(1). 651–651. 2 indexed citations

Li, Qingqing, Jing Yang, Shu Wang, et al.. (2024). Prognostic value of multi-PLD ASL-based cerebral perfusion ASPECTS in acute ischemic stroke. Frontiers in Neurology. 15. 1476937–1476937. 1 indexed citations

Jiang, Lai, Kan Wang, Fei Chen, et al.. (2024). Hierarchical joint analysis of marginal summary statistics—Part I: Multipopulation fine mapping and credible set construction. Genetic Epidemiology. 48(6). 241–257.

Chen, Fei, Sungshim L. Park, Lynne R. Wilkens, et al.. (2022). Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study. Cancer Research. 82(18). 3201–3208. 9 indexed citations

Chen, Fei, Peggy Wan, Lynne R. Wilkens, Loı̈c Le Marchand, & Christopher A. Haiman. (2022). The Association of Prediagnostic Statin Use with Aggressive Prostate Cancer from the Multiethnic Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 31(5). 999–1005. 1 indexed citations

Chen, Fei, et al.. (2021). Efficacy of second-line treatments for patients with advanced human epidermal growth factor receptor 2 positive breast cancer after trastuzumab-based treatment: a systematic review and bayesian network analysis. Journal of Cancer. 12(6). 1687–1697. 6 indexed citations

Yang, Liqun, Pengfei Shi, Gaichao Zhao, et al.. (2020). Targeting cancer stem cell pathways for cancer therapy. Signal Transduction and Targeted Therapy. 5(1). 8–8. 1349 indexed citations breakdown →

10.

Chen, Chao, et al.. (2019). Micheliolide inhibits gastric cancer growth in vitro and in vivo via blockade of the IL-6/STAT3 pathway.. PubMed. 74(3). 175–178. 24 indexed citations

11.

Chen, Fei, Eva P. Szymanski, Kenneth N. Olivier, et al.. (2017). Whole-Exome Sequencing Identifies the 6q12-q16 Linkage Region and a Candidate Gene, TTK , for Pulmonary Nontuberculous Mycobacterial Disease. American Journal of Respiratory and Critical Care Medicine. 196(12). 1599–1604. 23 indexed citations

12.

Chen, Fei, et al.. (2014). A liquid chromatography–tandem mass spectrometry-based targeted proteomics assay for monitoring P-glycoprotein levels in human breast tissue. Clinica Chimica Acta. 436. 283–289. 14 indexed citations

13.

Guan, Youfei, et al.. (2012). JNK-Dependent Stat3 Phosphorylation Contributes to Akt Activation in Response to Arsenic Exposure. Toxicological Sciences. 129(2). 363–371. 53 indexed citations

14.

Wang, Lei, Fei Chen, Zhuo Zhang, et al.. (2012). Cancer Stem Cells in the Mechanism of Metal Carcinogenesis. Journal of Environmental Pathology Toxicology and Oncology. 31(3). 245–263. 7 indexed citations

15.

Beezhold, Kevin, Jia Liu, Hong Kan, et al.. (2011). miR-190-Mediated Downregulation of PHLPP Contributes to Arsenic-Induced Akt Activation and Carcinogenesis. Toxicological Sciences. 123(2). 411–420. 88 indexed citations

16.

Wang, Kesheng, Gang Chen, Hailian Shen, et al.. (2011). Insulin Receptor Tyrosine Kinase Substrate Enhances Low Levels of MDM2-Mediated p53 Ubiquitination. PLoS ONE. 6(8). e23571–e23571. 18 indexed citations

17.

Zhang, Xin, Kesheng Wang, Tingting Li, et al.. (2010). Abstract 1008: IRTKS suppresses p53 activity through promoting MDM2 mediated p53 monoubiquitination. Cancer Research. 70(8_Supplement). 1008–1008. 1 indexed citations

18.

Zhang, Xin, Kesheng Wang, Zhiqin Wang, et al.. (2005). Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochemical and Biophysical Research Communications. 331(4). 1032–1038. 62 indexed citations

19.

Wickrema, Amittha, Fei Chen, Sarfraz Ahmad, et al.. (1999). Defective expression of the SHP-1 phosphatase in polycythemia vera. Experimental Hematology. 27(7). 1124–1132. 39 indexed citations

20.

Wickrema, Amittha, Shahab Uddin, Arun K. Sharma, et al.. (1999). Engagement of Gab1 and Gab2 in Erythropoietin Signaling. Journal of Biological Chemistry. 274(35). 24469–24474. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact